HOWARD HIRSCHFIELD: Open Payments
NPI 1306982541 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,174 in 59 payments from 14 companies in 2025. Trend: 2023 $1,469 · 2024 $982 · 2025 $1,174
Food & beverage: $1,174
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $225 |
| Janssen Biotech, Inc. | 14 | $204 |
| GENZYME CORPORATION | 8 | $182 |
| UCB, Inc. | 7 | $175 |
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| Regeneron Healthcare Solutions, Inc. | 3 | $89 |
| Paratek Pharmaceuticals, Inc. | 2 | $38 |
| Galderma Laboratories, L.P. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Solta Medical, a division of Bausch Health US, LLC | 1 | $22 |
Products named: DUPIXENT, TREMFYA, Bimzelx, RINVOQ, SKYRIZI, COSENTYX, NUZYRA, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
